参考文献
［1］Hundal R，Shaffer E A.Gallbladder cancer：epidemiology and outcome［J］.Clin Epidemiol，2014，6：99－109.
［2］Hneman M T，Vollmer J，Pawlik T M.Evolving treatment strategies for gallbladder cancer［J］.Ann Surg Oncol，2009，16（8）：2101－2115.
［3］Edge S B，Byrd D R，Compmn C C.AJCC Cancer Staging Manual.7th ed.New York：Springer，2009：191－209.
［4］Bosman F T，Carneiro F，Hruban R H，et al.WHO classification of tumours of the digestive system［M］.4th ed.Lyon：IARC Press，2010：217－224.
［5］Claessen M M，Vleggaar F P，Tytgat K M，Siersema P D，van Buuren H R.High lifetime risk of cancer in primary sclerosing cholangitis［J］.J Hepatol，2009，50：158－164.
［6］Razumilava N，Gores G J.Cholangiocarcinoma［J］.Lancet，2014，383（9935）：2168－2179.
［7］Khan S A，Thomas H C，Davidson B R.Cholangiocarcinoma［J］.Lancet，2005，366（9493）：1303－1314.
［8］Bennett S，Marginean E C，Paquing obeil M，et al.Clinical and pathological features of intraductal papillary pcoplasm of the biliary tract and gallbladder［J］.HPB，2015，17（9）：811－818.
［9］Isa T，Tomita S，Nakachi A，et al.Aalysis of microsatellite instability，Kras gene mutation and p53protein overexpression in intrahepatic cholangiocarcinoma［J］.Hepatogastroenterology，2002，49（45）：604－608.
［10］Qin X L，wang Z R，Shi J S，et al.Utility of serum CA199in diagnosis of cholangiocarcinoma in comparison with CEA［J］.World J Gastroenterol，2004，10930：427－432，(https://www.daowen.com)
［11］Chen C Y，Shiesh S C，Tsao H C，et al.The assessment of biliary CAl25，CAl99，and CEA in diagnosing hepatolithiasis［J］.Hepatogastroenterology，2002，49：616－620.
［12］Siqueira E，Schoen R E，Silveman W，et al.Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis［J］.Gastrointest Endose，2002，56：40－47.
［13］Yang N，Xia Y Y，Feng L，et al.Value of ultrasound－guided percutaneous transhepatic cholangio drainage in the treatment of obstructive jaundice［J］.Chin J Interv Imaging Ther，2012，（7）：494－496.
［14］Wei W，Ai H，Ruan L T，et al.Ultrasound－guided percutaneous transhepatic cholangiographic drainage in treatment of obstructive jaundice［J］.Chin J Interv Imaging Ther，2012，9（11）：782－785.
［15］Huang Y，Jiang Y G.Biliary tract stent implantation for palliative treatment of malignant obstructive jaundice［J］.Guide of China Medicine，2010，8（16）：121－122.
［16］Lu Q M，Wang X G，Ni Q F，et al.Effect of endoscopic retrograde biliary drainage in the treatment for patients with malignant obstructive jaundice and its influence on the cellular immunity［J］.Journal of Chinese Oncology，2013，19（6）：484－487.
［17］Liu C F，Guo Z，Sitong G.Analysis of factors influencing recurrent occlusion of metallic stents in malignant biliary obstruction［J］.J Intervent Radiol，2009，18（11）：850－852.
［18］Fei S X，Liu H C，Sun Z，et al.Evaluation of the curative effect of biliary stents combined with 125Iparticles for intracavitary treatment of malignant jaundice in cholangiocarcinoma［J］.Chin J Clin Oncol，2015，42（11）：564－569.
［19］Xiao Z Z，Cao J.Clinical observation on body gama－knife for the treatment of obstructive jaundice caused by cholangiocarcinoma［J］.Cancer research and clinic，2014，26（7）：473－475.
［20］Wang X，Li A C.Research advances in palliative treatment of cholangiocarcinoma［J］.J Clin Hepatol，2016，32（5）：1022－1025.